RWLK VS ICCC Stock Comparison

PerformanceAnalyst Price TargetsSentimentTechnicalsEarningsProfitVolatility
PerformanceAnalyst Price TargetsSentimentTechnicalsEarningsProfitVolatility

Performance

RWLK
10/100

RWLK returned -33.16% in the last 12 months. Based on SPY's performance of -21.08%, its performance is below average giving it a score of 10 of 100.

ICCC
10/100

ICCC returned -27.40% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

RWLK
80/100

5 analysts offer 12-month price targets for RWLK. Together, they have an average target of 3, the most optimistic target put RWLK at 3 within 12-months and the most pessimistic has RWLK at 3.

ICCC

"Analyst Price Targets" not found for ICCC

Sentiment

RWLK
70/100

RWLK had a bullish sentiment score of 69.59% across Twitter and StockTwits over the last 12 months. It had an average of 16.27 posts, 18.18 comments, and 54.60 likes per day.

ICCC
79/100

ICCC had a bullish sentiment score of 79.34% across Twitter and StockTwits over the last 12 months. It had an average of 2.67 posts, 0.00 comments, and 0.33 likes per day.

Technicals

RWLK
10/100

RWLK receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.

ICCC
64/100

ICCC receives a 64 of 100 based on 14 indicators. 8 are bullish, 4 are bearish.

Earnings

RWLK
10/100

RWLK has missed earnings 12 times in the last 20 quarters.

ICCC
44/100

ICCC has missed earnings 2 times in the last 20 quarters.

Profit

RWLK
10/100

Out of the last 20 quarters, RWLK has had 0 profitable quarters and has increased their profits year over year on 0 of them.

ICCC
31/100

Out of the last 20 quarters, ICCC has had 6 profitable quarters and has increased their profits year over year on 4 of them.

Volatility

RWLK
44/100

RWLK has had a lower than average amount of volatility over the last 12 months giving it a score of 44 of 100.

ICCC
49/100

ICCC has had a lower than average amount of volatility over the last 12 months giving it a score of 49 of 100.

All score calculations are broken down here to help you make more informed investing decisions

ReWalk Robotics Ltd Summary

Nasdaq / RWLK
Healthcare
Medical Devices
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Immucell Corp Summary

Nasdaq / ICCC
Healthcare
Biotechnology
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.